Contrasting Dynatronics (DYNT) and Iradimed (NASDAQ:IRMD)

Share on StockTwits

Iradimed (NASDAQ:IRMD) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Risk and Volatility

Iradimed has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.

Earnings and Valuation

This table compares Iradimed and Dynatronics’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Iradimed $30.44 million 8.98 $6.30 million $0.43 58.14
Dynatronics $64.42 million 0.27 -$1.60 million ($0.40) -5.25

Iradimed has higher earnings, but lower revenue than Dynatronics. Dynatronics is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Iradimed and Dynatronics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Iradimed 20.71% 14.26% 12.13%
Dynatronics -2.94% -10.67% -2.58%

Insider & Institutional Ownership

21.9% of Iradimed shares are owned by institutional investors. Comparatively, 13.0% of Dynatronics shares are owned by institutional investors. 61.2% of Iradimed shares are owned by company insiders. Comparatively, 44.0% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Iradimed and Dynatronics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iradimed 0 0 1 0 3.00
Dynatronics 0 0 1 0 3.00

Iradimed presently has a consensus price target of $35.00, suggesting a potential upside of 40.00%. Dynatronics has a consensus price target of $4.00, suggesting a potential upside of 90.48%. Given Dynatronics’ higher probable upside, analysts plainly believe Dynatronics is more favorable than Iradimed.

Summary

Iradimed beats Dynatronics on 10 of the 12 factors compared between the two stocks.

About Iradimed

IRadimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its MRI compatible products through direct sales force and independent distributors. IRadimed Corporation was incorporated in 1992 and is headquartered in Winter Springs, Florida.

About Dynatronics

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply